Michael Raymond Collins,Robert Steven Kania,Robert Arnold Kumpf,Pei-Pei Kung,Daniel Tyler Richter,Scott Channing Sutton,Martin James Wythes
申请号：
US16156304
公开号：
US10570121B2
申请日:
2018.10.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention relates to compounds of general formula (I)in which R1, R2, R3, R4, L, X and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
